Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomised, Uncontrolled, Single-Centre, Post-Market Surveillance Study To Evaluate The Performance Of SmartSet® HV and SmartSet® GHV Bone Cements In Primary Cemented Total Hip Arthroplasty(THA)

NCT00872066 is registered in ClinicalTrials.gov with DePuy International as lead sponsor.

NCT NCT00872066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomised, Uncontrolled, Single-Centre, Post-Market Surveillance Study To Evaluate The Performance Of SmartSet® HV and SmartSet® GHV Bone Cements In Primary Cemented Total Hip Arthroplasty(THA)
Lead sponsor
DePuy International
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2016
Enrollment
243 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, collagen disorders, congenital hip dysplasia, nonunion of femoral fractures, osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, slipped capital femoral epiphysis, traumatic femoral fractures